NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹3,371 Cr | ₹4,327 Cr | ₹3,051 Cr | ₹2,317 Cr | ₹1,776 Cr |
What is the latest Net Current Assets ratio of NATCO PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹3,371 Cr |
| Mar2025 | ₹4,327 Cr |
| Mar2024 | ₹3,051 Cr |
| Mar2023 | ₹2,317 Cr |
| Mar2022 | ₹1,776 Cr |
How is Net Current Assets of NATCO PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,371 Cr | -22.08 | |
| Mar2025 | ₹4,327 Cr | 41.82 | |
| Mar2024 | ₹3,051 Cr | 31.65 | |
| Mar2023 | ₹2,317 Cr | 30.45 | |
| Mar2022 | ₹1,776 Cr | - | |
Compare Net Current Assets of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹14,576.9 Cr | -0.2% | -8.3% | -5.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -0.2% |
-8.3% |
-5.1% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses